These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30053268)

  • 1. ADReCS-Target: target profiles for aiding drug safety research and application.
    Huang LH; He QS; Liu K; Cheng J; Zhong MD; Chen LS; Yao LX; Ji ZL
    Nucleic Acids Res; 2018 Jan; 46(D1):D911-D917. PubMed ID: 30053268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADReCS: an ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms.
    Cai MC; Xu Q; Pan YJ; Pan W; Ji N; Li YB; Jin HJ; Liu K; Ji ZL
    Nucleic Acids Res; 2015 Jan; 43(Database issue):D907-13. PubMed ID: 25361966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mining drug-target and drug-adverse drug reaction databases to identify target-adverse drug reaction relationships.
    Galletti C; Bota PM; Oliva B; Fernandez-Fuentes N
    Database (Oxford); 2021 Oct; 2021():. PubMed ID: 34679164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the common genetic networks of ADR (adverse drug reaction) clusters and developing an ADR classification model.
    Hwang Y; Oh M; Jang G; Lee T; Park C; Ahn J; Yoon Y
    Mol Biosyst; 2017 Aug; 13(9):1788-1796. PubMed ID: 28702565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale identification of adverse drug reaction-related proteins through a random walk model.
    Chen X; Shi H; Yang F; Yang L; Lv Y; Wang S; Dai E; Sun D; Jiang W
    Sci Rep; 2016 Nov; 6():36325. PubMed ID: 27805066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filtering big data from social media--Building an early warning system for adverse drug reactions.
    Yang M; Kiang M; Shang W
    J Biomed Inform; 2015 Apr; 54():230-40. PubMed ID: 25688695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A web resource for mining HLA associations with adverse drug reactions: HLA-ADR.
    Ghattaoraya GS; Dundar Y; González-Galarza FF; Maia MH; Santos EJ; da Silva AL; McCabe A; Middleton D; Alfirevic A; Dickson R; Jones AR
    Database (Oxford); 2016; 2016():. PubMed ID: 27189608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Adverse Reaction Target Database (DART) : proteins related to adverse drug reactions.
    Ji ZL; Han LY; Yap CW; Sun LZ; Chen X; Chen YZ
    Drug Saf; 2003; 26(10):685-90. PubMed ID: 12862503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontology-based literature mining and class effect analysis of adverse drug reactions associated with neuropathy-inducing drugs.
    Hur J; Özgür A; He Y
    J Biomed Semantics; 2018 Jun; 9(1):17. PubMed ID: 29880031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
    Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
    BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network characteristic analysis of ADR-related proteins and identification of ADR-ADR associations.
    Chen X; Liu X; Jia X; Tan F; Yang R; Chen S; Liu L; Wang Y; Chen Y
    Sci Rep; 2013; 3():1744. PubMed ID: 23625301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.
    Ross CJ; Visscher H; Sistonen J; Brunham LR; Pussegoda K; Loo TT; Rieder MJ; Koren G; Carleton BC; Hayden MR;
    Thyroid; 2010 Jul; 20(7):681-7. PubMed ID: 20578893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic analysis of the associations between adverse drug reactions and pathways.
    Chen X; Wang Y; Wang P; Lian B; Li C; Wang J; Li X; Jiang W
    Biomed Res Int; 2015; 2015():670949. PubMed ID: 26495310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
    Wu L; Ingle T; Liu Z; Zhao-Wong A; Harris S; Thakkar S; Zhou G; Yang J; Xu J; Mehta D; Ge W; Tong W; Fang H
    BMC Bioinformatics; 2019 Mar; 20(Suppl 2):97. PubMed ID: 30871458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the associations between drug side-effects and therapeutic indications.
    Wang F; Zhang P; Cao N; Hu J; Sorrentino R
    J Biomed Inform; 2014 Oct; 51():15-23. PubMed ID: 24727480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of adverse drug reactions using drug and drug target interactions and graph-based methods.
    Lin SF; Xiao KT; Huang YT; Chiu CC; Soo VW
    Artif Intell Med; 2010; 48(2-3):161-6. PubMed ID: 19962282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving drug safety: From adverse drug reaction knowledge discovery to clinical implementation.
    Tan Y; Hu Y; Liu X; Yin Z; Chen XW; Liu M
    Methods; 2016 Nov; 110():14-25. PubMed ID: 27485605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A portable database of adverse reactions and drug interactions with radiopharmaceuticals.
    Gómez Perales JL; Martínez AA
    J Nucl Med Technol; 2013 Sep; 41(3):212-5. PubMed ID: 23857419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad-Spectrum Profiling of Drug Safety via Learning Complex Network.
    Liu K; Ding RF; Xu H; Qin YM; He QS; Du F; Zhang Y; Yao LX; You P; Xiang YP; Ji ZL
    Clin Pharmacol Ther; 2020 Jun; 107(6):1373-1382. PubMed ID: 31868917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.